T1	Participants 178 243	Twenty-eight newly diagnosed patients with small cell lung cancer
T2	Participants 435 582	Complete responses (CR) were achieved in 57% of patients receiving high-dose therapy as compared to 21% of patients receiving standard-dose therapy
T3	Participants 615 668	higher rate of severe toxicity in the high-dose group
T4	Participants 954 1023	These effects were most pronounced in patients with extensive disease
T5	Participants 1025 1159	a CR after induction was achieved in five of nine patients treated with high doses but not in any of those treated with standard doses
T6	Participants 1180 1296	A small group of patients appear to benefit by achieving a long-term remission with intensive induction chemotherapy
